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Abstract.  Analysis by SDS-PAGE of gap junction 
fractions isolated from heart suggests that the junctions 
are comprised of a protein with an Mr 43,000.  Anti- 
bodies against the electroeluted protein and a peptide 
representing the 20 amino terminal  residues bind 
specifically on immunoblots to the 43-kD protein and 
to the major products arising from proteolysis during 
isolation.  By immunocytochemistry, the protein is 
found in ventricle and atrium in patterns consistent 
with the known distribution of gap junctions.  Both an- 
tibodies bind exclusively to gap junctions in fractions 
from heart examined by EM after gold labeling.  Since 
only domains of the protein exposed at the cytoplas- 
mic surface should be accessible to antibody, we con- 
clude that the 43-kD protein is assembled in gap junc- 
tions with the amino terminus  of the molecule exposed 
on the cytoplasmic side of the bilayer, that is, on the 
same side as the carboxy terminus  as determined pre- 
viously. By combining proteolysis experiments with 
data from immunoblotting,  we can identify a third cy- 
toplasmic region, a  loop of some 4  kD between mem- 
brane protected domains.  This loop carries an anti- 
body binding site. The protein,  if transmembrane,  is 
therefore likely to cross the membrane four times. We 
have used the same antisera to ascertain if the 43-kD 
protein is involved in cell-cell communication.  The 
antiserum against the amino terminus blocked dye 
coupling in 90%  of cell pairs tested; the antiserum 
recognizing  epitopes in the cytoplasmic loop and cyto- 
plasmic tail blocked coupling in 75 % of cell pairs 
tested.  Preimmune serum and control antibodies (one 
against MIP and another binding to a cardiac G pro- 
tein) had no or little effect on dye transfer.  Our ex- 
perimental evidence thus indicates that,  in spite of the 
differences in amino acid sequence, the gap junction 
proteins in heart and liver share a general organiza- 
tional plan and that there may be several domains (in- 
cluding the amino terminus)  of the molecule that are 
involved in the control of junctional permeability. 
T 
HE cells of cardiac muscle (for review, see Page and 
Manjunath,  1986), and those in most tissues of organ- 
isms throughout  the animal  kingdom,  are intercon- 
nected by channels that provide a low resistance  pathway for 
the passage of ions and small molecules. These channels col- 
lectively form the membrane specialization  known as the gap 
junction (Revel and Karnovsky,  1967) or nexus (Dewey and 
Barr,  1962; 1964). In the intact heart, gap junctions provide 
cell-to-cell  electrical continuity.  Such connections are be- 
lieved important in supporting the coordinated contraction of 
myocytes, allowing the heart to perform as an effective pump 
(Barr et al., 1965; De Mello, 1977; Joyner,  1982; Spach and 
Kootsey,  1983; Fozzard and Arnsdorf,  1986).  Presumably 
the synchronous beating of cardiac myocytes in cell culture 
is a reflection of the transmission  of electrical signals via gap 
junctional channels (De Haan and Hirakow, 1972; Griepp and 
Bernfield, 1978; Griepp et al.,  1978; De Haan et al.,  1981; 
however see Sperelakis and Mann,  1977; Williams  and De 
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Haan, 1981). Rapid propagation of electrical signals and syn- 
chronization  of activity are postulated roles of the gap junc- 
tions  in other excitable  tissues (Robertson,  1963; Bennett, 
1977). In nonexcitable tissues, and probably in heart as well, 
gap junctions mediate the cell-to-cell  traffic of metabolites 
and may carry signal  molecules for the control of growth, 
embryonic development, and cellular differentiation  (Pitts, 
1978; Loewenstein,  1979; Warner et al., 1984; Revel, 1986; 
Fraser et al.,  1987; Gilula et al.,  1987). 
Until recently, much of our understanding  of the molecular 
organization  of gap junctional channels  has come from the 
characterization  of the junctions from liver where it has been 
shown that cell-cell connections are formed by the end-to- 
end interaction  of hemichannels  (connexons)  comprised of 
six protein subunits (Unwin and Zampighi,  1980). In the first 
models proposed, each protein was believed to be a polypep- 
tide of M, 28 kD (Makowski et al.,  1977; Makowski,  1985). 
In the last few years, however, there has been a growing real- 
ization that gap junctions from different tissues may differ in 
their protein components (Nicholson et al., 1985; Manjunath 
and Page,  1986;  Manjunath et al.,  1987; Gruijters et al., 
1987) and that even within a single cell more than one kind 
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al.,  1987; Revel et al., 1986;  1987).  Gap junctions isolated 
from heart appear to contain a major component that mi- 
grates, depending on the gel system, between '~43 and 47 
kD (Manjunath et al., 1984), but has a true molecular mass 
of 43 kD as determined by DNA sequencing (Beyer et al., 
1987); junctions from liver (Nicholson et al., 1987; Revel et 
al., 1986;  1987) are now known to be comprised of two pro- 
teins that migrate at ~28 and 21 kD but have an actual molec- 
ular mass of 32 and 26 kD, respectively (Paul, 1986; Kumar 
and Gilula, 1986; Nicholson and Zhang, 1988). The known 
heart and liver proteins are related to each other at the level 
of '~50 % homology as first indicated by a comparison of the 
amino terminal sequences obtained by protein sequencing 
(Nicholson et al.,  1981; 1985;  1987)  and later confirmed 
when their complete amino acid sequences became known 
from cDNA cloning (Paul, 1986; Kumar and Gilula, 1986; 
Heynkes et al.,  1986;  Beyer et al,  1987; Nicholson and 
Zhang, 1988). More recently, another protein with sequence 
homology, but with an Mr of 70 kD, has been identified in 
the lens (Kistler et al., 1988).  Other proteins, not related to 
those above, have also been proposed as components of ver- 
tebrate gap junctions, notably a polypeptide of 16 kD present 
in many different tissues including liver and heart (Finbow 
et al., 1985) and the main intrinsic polypeptide (MIP) of lens 
fiber cell membranes (Johnson et al., 1985). Of all these pro- 
teins, only the 32-kD protein from liver and the 70-kD pro- 
tein from the lens have been unequivocally localized to gap 
junctions (Paul,  1986;  Zimmer et al.,  1987; Dermietzel et 
al., 1987; Gruijters et al., 1987; Milks et al., 1988). In addi- 
tion, immunofluorescence staining of the 32- and 26-kD pro- 
teins of liver shows that they colocalize. Thus, the 26 kD also 
is likely a junction protein (Nicholson et al.,  1987). 
The specific properties of  gap junction channels of particu- 
lar organs may be due to differences in the proteins leading 
to a distinctive organization of the channels or to differential 
sensitivity to signals. The theoretical predictions about the 
organization of gap junction proteins in membranes which 
can be made on the basis of analysis of the sequence (Schultz, 
1988) must be tested experimentally. Milks et al. (1988) have 
just published such a study for the 32-kD hepatic gap junc- 
tion protein; the work we present here shows that the heart 
junction protein has the same general structural features. By 
immunocytochemistry with an antibody against the 43-kD 
protein from heart and an antipeptide antibody against its 
amino terminus, we demonstrate that this protein is distrib- 
uted in the heart in the pattern one would expect if it were 
a  major component of gap junctions.  We  show that it is 
specifically localized to gap junctions in fractions isolated 
from heart. We present direct evidence that the amino termi- 
nus is exposed at the cytoplasmic surface of the junction and 
that there is a cytoplasmic loop. Since the carboxy terminus 
of the molecule is already known to be cytoplasmic (Man- 
junath et at., 1987), the molecule could cross the membrane 
four times. By combining results produced by immunolocal- 
ization and biochemical dissection, we construct a  model 
that confirms several  aspects of the theoretical predictions 
which can be made on the basis of the cDNA-derived amino 
acid sequence (Beyer et al.,  1987). 
1. Abbreviations used in thispaper:  LY, Lucifer yellow; MIP, main intrinsic 
polypeptide; TR, Texas red. 
The topological data is of particular interest when com- 
bined with physiological information on gap junctions ob- 
tained by measurement of their electrical properties and of 
the extent of dye coupling. The activity of the gap junction 
channels has been reported to be gated by changes in pH, 
pCa,  membrane  potential  and  second  messengers  (for 
reviews, see Spray and Bennett,  1985;  Bennett and Spray, 
1987).  It is tempting to hypothesize that the tissue-specific 
differential gating of physiological activity may result from 
the biochemical diversity of the gap junctions. As a first step 
in testing this idea, we have asked if separate functional do- 
main(s) in gap junction proteins can be recognized using an- 
tibodies raised against identified epitopes of these proteins. 
The antibodies we have characterized inhibit dye coupling 
between neonatal rat cardiac muscle cells in culture. Thus, 
a domain at the amino terminus and epitopes located in other 
parts of the 43-kD heart protein could independently be in- 
volved in controlling cell-cell communication via gap junc- 
tions. 
Materials and Methods 
Preparation of  Membrane and Gap Junction- 
Enriched Fractions 
Crude plasma membranes and gap junction enriched fractions were isolated 
from the hearts of rats (300-350 g male Sprague-Dawley from Simonsen 
Laboratories, Gilroy, CA; or Bantin and Kingman, Fremont, CA). Plasma 
membranes were prepared according to the methods described by Man- 
junath et al.  (1985)  and gap junctions according to Manjunath and Page 
(1986).  Partially purified preparations were obtained by using sarkosyl con- 
centrations <0.3%  for membrane solubilization. In our hands, concentra- 
tions of  0.35 % were needed to yield consistently high purification (but lower 
yields) of gap junctions. Protein recovery was estimated by densitometry of 
Coomassie stained gels. 
SDS-PAGE 
Aliquots of the fractions were solubilized at room temperature in buffer 
(final  concentration of 2 % SDS, 5 % beta-mercaptoethanol, 5 % glycerol, 
0.004%  bromophenol blue, and 0.03  M Tris-HCL, pH 6.8) and analyzed 
on 15 % polyacrylamide gels. The following low molecular weight standards 
(provided by Bio-Rad Laboratories,  Cambridge, MA) were used:  phos- 
phorylase B, 97,400;  BSA, 66,200; ovalbumin, 42,700; carbonic anhydrase, 
31,000;  soy bean trypsin inhibitor, 21,500;  lysozyme, 14,400.  The size of 
the fragments produced by exogenous proteases was obtained using a Turbo 
Pascal implementation of the program "Gel" described by  Schaffer and 
Sederoff (1981), but is only an approximation of the true molecular mass 
because of the anomalous behavior of very hydrophobic polypeptides in 
SDS-PAGE (Isaac et al.,  1985). 
Preparation of  Antibodies against 
Heart Gap Junctions 
Both antisera were produced in New Zealand White rabbits. 
Anti-43-kDAntibody.  Purification of  43-kD protein: gap junctions were 
isolated from whole rat hearts as described by Manjunath and Page (1986), 
except that the preparations were scaled up to 32 rats and sarkosyl detergent 
treatment was varied to optimize the yield. The 43-kD protein to be used 
as immunogen was electroeluted from bands excised from 10% preparative 
gels after brief staining with Coomassie blue and partial destaining. Elec- 
troelutions were carried out in a Schleicher and Schuell Elutrap, using stan- 
dard Tris-glycine electrophoresis buffer containing 0.1% dithiothreitol. The 
electroeluted protein was analyzed on 15 % polyacrylamide gels and also on 
nitrocellulose blots for immunoreactivity with the anti-amino terminus an- 
tibody (see below). The protein was lyophil[zed before resuspension, emul- 
sification, and injection. 
Production  of Antibody.  One rabbit was injected with 40/~g of electro- 
eluted protein mixed l:l with complete Freund's adjuvant. Approximately 
25 % of the emulsion (50-75 ~l) was injected into each popliteal lymph node; 
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4 wk and 6 mo after the first injection, 150-180  #g of electroeluted protein 
in incomplete Freund's adjuvant was injected, 50% subcutaneously in the 
neck and 25%  intramuscularly in each hind leg near the popliteal nodes. 
Blood was taken 10 d after each boost and then at  1-wk intervals. 
Affinity Purification.  Specific antibodies were isolated from the immune 
serum by affinity purifcation against the 43-kD protein using the Olmsted 
technique (Olmsted,  1981). Components of the gap junction preparations 
were electrophoretically separated and blotted to nitrocellulose by semi-dry 
electrotransfer in CAPS buffer (10 mM 3-[cyclohexylamino]-l-propanesul- 
fonic acid, pH 11) with 10% methanol (vol/vol) and 0.1% SDS. The blots 
were stained with Ponceau-S, and the 43-kD band was excised and cut into 
small squares. The squares were treated with blocking solution (3 % BSA 
in TBS with 0.1% Tween 20), and then incubated with the antiserum. The 
bound antibody was eluted with 3 M KSCN, and then passed over an acryl- 
amide buffer-exchange column  (Beckman Instruments,  Inc.,  Palo Alto, 
CA). Antibody concentration was determined by optical density measure- 
ments (I  nag is equal to  1.40D units at 280 nm). 
Anti-Amino Terminus Antibody.  Synthesis and conjugation of the pep- 
tide: a peptide corresponding to the amino terminal 20 residues of the ma- 
ture heart 43-kD protein as determined by Nicholson et al. (1985),  with a 
glycine and a cysteine residue added at the carboxy terminus for purposes 
of cross-linking, was synthesized on a peptide synthesizer (Applied Bio- 
systems, Inc., Foster City, CA) (S.  Kent, California Institute of Technol- 
ogy). The peptide differs from the cDNA-derived sequence (Beyer et at., 
1988) at position 1 of the protein sequence by having an Ala instead of a 
Gly. Fully reduced crude peptide (24 mg) was conjugated through its car- 
boxy terminal cysteine to Keyhole limpet hemocyanin (6 mg) using the bi- 
functional cross-linker succinimidyl-4-(N-maleimidomethyl)-cyclohexane- 
1-carboxylate  (Pierce Chemical Co., Rockford, IL). 
Production of the Antibody.  1.25 mg of the conjugate were suspended 
in Freund's complete adjuvant (in a ratio of 1:2) and injected, ,x66%  in- 
tradermally at multiple sites on the back and 33 % intramuscularly in the 
hind  limb adjacent to  the pepliteal  node.  The  rabbit was subsequently 
boosted with 500 #g of conjugate, prepared similarly, at 2 and 4 mo after 
the first injection and then 1 yr later. Titers >1 in 10,000 against the peptide 
were consistently obtained in bleeds 1-3 wk following each boost. 
Affinity Purification. Crude peptide (5-7 nag) was conjugated via Schilt's 
base to the free aldehyde groups on the membrane filter of a MAC-25 car- 
tridge (Memtek Corporation, Billerica, MA) in accordance with the manu- 
facturer's instructions. After blocking, specific antibody was bound by pass- 
ing 500 #1 of serum through the filter. After several washes with PBS/0.1% 
Tween 20, the bound antibody was eluted with 0.1 M glycine at pH 2.2 and 
immediately equilibrated with PBS/0.01%  sodium azide by passage over a 
Sephadex G50 spun column. 
Characterization of  Antisera 
Western Blots.  Components of the gap junction enriched fractions were 
separa~d on 15% polyacrylamide gels and transferred to nitrocellulose as 
described above. The blots were treated with blocking solution, then in- 
cubated with the primary antibody diluted in TBS with 0.1%  Tween 20 
(TBST), washed in TBST, and reacted with goat anti-rabbit IgG (Fc) con- 
jugated to alkaline phosphatase (Promega Biotec, Madison, WI). Reaction 
with the enzyme substrate and color development were performed accord- 
ing to the instructions of the supplier. Strong signals were obtained with the 
anti--43-kD antiserum at 1:1,000 dilution and the anti-amino terminal anti- 
serum at  1:5,000 dilution. 
ELISA.  Assays for binding of antisera to the peptide were performed 
using the ELISAmate kit (Kirkegaard & Perry Laboratories, Inc., Gaithers- 
burg, MD). The peptide (100 #g/mi of binding solution) was bound to the 
wells of microtiter plates, incubated sequentially with serial dilutions of the 
primary antiserum, peroxidase-labeled protein A, and the peroxidase sub- 
strate solutions supplied by the manufacturer. 
Antibodies not Directed against Heart Gap Junctions 
Besides preimmune serum, we also used a site-specific antiserum against 
the synthetic peptide corresponding to the amino acid sequence 234-245 of 
rat lens MIP (Gorin ct al., 1984) and an affinity purified site-specific anti- 
body against a synthetic peptide representing the 14 NHz-terminal amino 
acids of the beta 1 suhunit of a G protein from HL-60 myeloid cell mem- 
branes (Amatruda et al.,  1988).  By Western blot assay, the latter antibody 
reacts with high specificity with G protein in rat cardiac plasma membranes. 
Strong signals were obtained in Western blots with a 1:5,000 dilution of the 
antiserum and a  1:1,000 dilution of the affinity purified antibody. 
lmmunofluorescence and lmmunogold Labeling with 
Silver Enhancement 
Animals, similar to those used for isolation of gap junctions, were anesthe- 
tized with ether and perfused through the left ventricle with PBS. Papillary 
muscle and small pieces of tissue from atrial and ventricular muscle and 
from liver were frozen in Freon 22 at its melting temperature and then stored 
in liquid nitrogen. Cryosections (,x,10 #m thick) were fixed in absolute etha- 
nol for 30 rain at -20°C and then processed at room temperature for im- 
munofluorescence or immunogold labeling with silver enhancement. 
For immunofluorescence, the sections were washed in PBS, treated with 
I% BSA in PBS for 20 min, and then incubated for 1 h with antisera or 
affinity purified antibody in PBS with  1%  BSA (antisera at a dilution of 
!:100,  affinity-purified antibody at 80-100/~g/ml for the anti-43-kD anti- 
body or 40 #g/ml for the anti-amino terminus antibody).  For controls, 
preimmune sera were used at a dilution of 1:50 or sections were reacted with 
second antibody alone. After washes in PBS containing 1% BSA and 0.1% 
Tween 20,  the sections were incubated with fluorescein-conjugated goat 
anti-rabbit IgG (Gibco Laboratories, Grand Island, NY) at a dilution of 
1:500.  Sections were photographed by epifluorescence on a  Zeiss micro- 
scope equipped with the appropriate filters. 
For immunogold labeling with silver enhancement, sections of longitudi- 
nally oriented papillary muscle were processed according to the protocol 
recommended by Boehringer Mannheim Biochemicals (Indianapolis, IN). 
The sections were blocked with 5% normal goat serum and 0.1% BSA in 
TBS, and then incubated sequentially with affinity-purified  anti-43-kD anti- 
body diluted to 20 p,g/ml in 1% normal goat serum, 0.1% BSA in TBS, and 
5 nm colloidal gold-labeled goat anti-rabbit IgG (Boehringer Mannheim 
Biochemicals) diluted 1/40 in 0.4 % gelatin, 0.1% BSA in TBS. After washes 
in PBS, the sections were postfixed in 2% glutaraldehyde in PBS for 15 
min, washed in PBS and then in distilled water.  To make the gold visible 
in the light microscope, metallic silver was deposited on the gold particles 
according to the protocol suppliec1 with the silver enhancement kit from 
Boehringer Mannheim Biochemicals. 
Immunogold EM 
All reactions were done at room temperature in microfuge tubes with fre- 
quent mixing to resuspend the membranes that otherwise tended to pellet. 
About 25 trg of a crude plasma membrane fraction or 15 #g of a gap junction 
enriched fraction were suspended in 200 #1 of 5% BSA in PBS for a 15 rain 
block before addition of  the antisera. Either antiserum or preimmune serum 
was then added to give a final dilution of 1:20, 1:50, or 1:100 and then in- 
cubated for 90 min. Membranes were pelleted at 15,000 rpm in a microfuge 
(Wheaton Instruments, Millville, NJ), washed with PBS, and then incubated 
for 90 min in 5 nm colloidal gold-labeled goat anti-rabbit IgG, diluted 1:10, 
1:20, or 1:40 in 5% BSA in PBS. After thorough washes in PBS, the pellets 
were fixed in 2% glutaraldehyde in 0.1 M cacodylate buffer, pH 7.2, post- 
fixed in  1% osmium tetroxide, en bloc stained with uranyl acetate, dehy- 
drated, and embedded in Epon. Thin sections were stained with lead citrate 
and uranyl acetate and examined on an electron microscope (model 420; 
Philips Electronic Instruments, Inc., Mahwah, NJ). 
Proteolysis of  Isolated Junctions 
Protease digestions were carried out on isolated junctions in suspension at 
37°C. The proteases endoproteinase Lys-C, endoproteinase GIu-C, and L-I- 
p-tosylamino-2-phenylethyl  chloromethyl  (TPCK)  trypsin  (Boehringer 
Mannheim Biochemicals) were all used in 0.1 M phosphate buffer, pH 8. 
The total incubation volume was 30 #1. For controls, parallel incubations 
were carried out on isolated junctions treated with buffer alone. For diges- 
tions to go to completions, proteases were added at time 0, a second addition 
was made after 2 h, and the incubations were continued overnight (total time 
16 h). The final enzyme to substrate ratio was 1:20-1:10. For partial proteol- 
ysis, the reaction was stopped 30 min after adding the protease. 
Suspensions of junctions in  buffer containing protease were spun at 
15,000 g for 10 rain. The supernatant was removed and the junction pellet 
washed by resuspending in 0.1 M phosphate buffer and spinning a second 
time. To inactivate any remaining proteases, the  junctional pellet was treated 
with 10 #1 of 0.01 M HCi in water before solubilization of the junctions in 
4  ×  solubilization buffer (8% SDS, 20% mercaptoethanol, 0.125  M Tris- 
HCI, pH 6.8).  Water was then added to the solubilized junctions to bring 
the concentration down to the equivalent of 1  ×  solubilization buffer for 
analysis of the junctions by SDS-PAGE. 
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1Issue Culture. Neonatal rat hcart muscle cells were cultured by a proce- 
dure modified from Griepp and Bernfield (1978). Briefly, hearts of 1-d-old 
rats were dissected, minced, and incubated at 37°C for 10 min in a Ca- and 
Mg-free Earle's balanced salt solution. The minced tissue was dissociated 
by repeated treatment with 0.5% trypsin (hog pancreas; ICN Biomedicals, 
Cleveland, OH) in Ca- and Mg-free Earle's balanced salt solution, and me- 
chanical stirring.  The dissociated cells were filtered through 43-/zm Nytex 
mesh to remove undissociated pieces. Cells were maintained in medium 199 
(Gibco Laboratories; with 25 mM Hepes, Earl's salts, and L-glutamate) to 
which K-free Earle's balanced salt solution, antibiotics, FCS, and horse sera 
were added.  The pH of the medium  was maintained at 7.4 with  15 mM 
N-tris(hydroxymethyl)methyl-2-aminoethane  sulfonate-Hepes  buffer. The 
medium also contained 10/~M cytosine-o arabinofuranoside (Sigma Chemi- 
cal Co., St. Louis, MO) to inhibit the growth of fibroblasts in the muscle 
cell cultures. Most of the fibroblasts from the original cell suspension were 
removed by first plating on glass dishes. Myocytes, but not fibroblasts, were 
detached by gentle shaking,  1.5 h after initial plating.  Fractions enriched 
in myocytes were then replated at low density. Cells were maintained in an 
incubator in humidified air at 37°C. After 36-48 h, cells were observed to 
beat rhythmically. Myocytes kept in culture for 4-6 d were used in the pres- 
ent study. During an experimental period,  the medium was changed every 
2-3 h. The pH of the medium was checked regularly and maintained at 7.4 
with TES-Hepes  buffer. 
lntracellularlnjection of  Dyes  and  Antibodies. The dyes used for label- 
ing in our experiments were: Lucifer yellow Ch (LY) (457 mol wt; Aldrich 
Chemical Co., Milwaukee, WI), Texas Red (TR) (625 mol wt; Molecular 
Probes Inc., Junction City, OR), and Rhodamine-labeled dextmn (molecu- 
lar weight: 10,000; Molecular Probes Inc.). All dyes were dissolved in 0.15 
M lithium chloride (LiCI) buffered to pH 7.6 with 10 mM Hepes. The con- 
centration (wt/vol) of these solutions were the following: 5 % for LY, 0.2 % 
for TR, and 30% for rhodamine-labeled dextran. TR and LY were selected 
as tracers because of their distinct and nonoverlapping excitation and emis- 
sion peaks:  they could be detected separately using appropriate  filters. 
For dye coupling  experiments,  aliquots of the antibodies  were freshly 
thawed and filtered using Centrex disposable microfilter units (0.2 #m pore 
nylon  mesh;  Schleicher  &  Schuell,  Keene,  NH).  The  supernatant  was 
diluted 1:4 in filtered (0.22/~m filter) solutions of 0.15 M LiC1 buffered to 
pH 7.6 with 10 mM Hepes. All of the antibodies used reacted well with their 
specific antigens at roughly the same concentration.  Dilutions of  the various 
antibodies that gave strong signals in Western blots were 1:5,000 for the an- 
tiserum  and  1:1,000 for the affinity purified  antibody  to the G protein, 
1:5,000 for the antiserum to the amino terminus of the 43-kD gap junction 
protein,  and  1:1,000 for the antiserum to the electroeluted 43-kD protein. 
For intracellular  injections,  microelectrodes  were drawn from Omega 
Dot borosilicate tube (outer diameter  1.2 mm; A-M Systems Inc.,  Everett, 
WA). The electrodes  were  connected  to  electrometers  containing  active 
bridge circuits (8800 total clamp; DAGAN  Corp., Minneapolis,  MN) and 
usually had a resistance of 25-50 megohms when filled with 0.15 M LiCI. 
For most studies, isolated pairs of cells were selected that had spontaneous 
rhythmic synchronous contractions.  Occasionally, somewhat larger groups 
of cells were used. Action potentials and resting membrane potentials were 
monitored. Only those cells that showed a sizeable resting potential (-50 to 
-70 mV) were used in our studies. Spontaneous action potentials were fre- 
quently observed. The electrode impalements were accompanied by a large 
shift in the membrane potential. Each dye or antibody was injected through 
separate microelectrodes.  Dyes were injected by passing 3-10  nA hyper- 
polarizing (negative) current pulses at 1 Hz for 20-30 s or ,x,5 nA negative 
DC currents for 2-5 min. Occasionally, dyes would diffuse passively (prob- 
ably when an electrode  tip diameter  was large). Antibodies were injected 
by passing 20-30 nA negative current pulse at 1 Hz for 30-40 s or ,'-80-100 
nA negative DC current for 2-5 s. These parameters for antibody injections 
are comparable to those used by other investigators (Hertzberg et al., 1985). 
Under these conditions, there was no detectable change in the injected cell's 
volume. Dye injection and spread were monitored on a fluorescence micro- 
scope (Carl Zeiss, Inc., Thornwood, NY) with 75 W xenon arc lamp illumi- 
nation using epifluorescence optics with appropriate excitation and barrier 
filters (LY: exciter filter, 485 nm, barrier filter, 520 nm, and an additional 
kp 560 filter; TR: exciter filter, 540 rim, barrier filter, 590 am). Optical im- 
ages were stored on videotapes through a silicon intensified tube camera 
(RCA, Lancaster, PA) for further  analysis. The extent of dye spread was 
recorded on ultrafast color films (sr-v 3200; Konika USA Inc.,  Englewood 
Cliffs, NJ) using a camera  (UFX-II;  Nikon Inc., Garden  City, NY), 3-5 
min after the injection of  dyes. Phase optics were also available on the same 
microscope. 
Figure  1.  Coomassie-stained 
SDS  polyacrylamide  gel  of 
gap  junction  fractions.  The 
position of the low molecular 
weight  standards  (Bio-Rad 
Laboratories) are indicated on 
the left with molecular weights 
in thousands.  Lane 1, a highly 
purified gap junction fraction 
typical of those obtained with 
the  scaled-up  protocol.  The 
fraction contains a major com- 
ponent migrating at about 43 
kD.  In this  overloaded  lane, 
one also sees bands at 35, 33, 
and 31 kD that have previously 
been shown to represent prod- 
ucts of the proteolysis of the 
43-kD  protein  during  isola- 
tion. Only minor contaminants 
can  be  detected.  Lane  2,  a 
partially purified gap junction 
preparation  such  as  used  for 
testing  the  specificity  of the 
antibodies. 
Results 
Both Antibodies Bind Specifically to the 43-kD Protein 
and the Major Products of Its Proteolysis 
The purity of the protein we obtain is usually good, showing 
only a  single major band  at 43  kD even in overloaded gels 
(Fig.  1).  When  testing  the  specificity  of the  antibodies  on 
Western  blots,  however,  it is  advantageous  to  use  partially 
purified preparations  (Fig.  1). 
The antipeptide  antiserum  was  raised  against a  synthetic 
peptide representing the amino terminal 1-20 residues of the 
protein sequence; by ELISA, this antiserum binds with high 
titer to the peptide (data not shown).  Both the antipeptide an- 
tiserum and affinity purified antibody  derived from it (Fig. 
2) bind to bands  at Mr 43,  35,  33,  and  31  kD,  which repre- 
sent the native protein and its three major breakdown  prod- 
ucts  (Manjunath  et al.,  1984).  Proteolytic  cleavage during 
isolation  occurs  at  the  carboxy  terminus  and  all  products 
seen by SDS-PAGE retain the amino terminus of the parent 
molecule (Manjunath  et al.,  1987). 
Blots probed  with the polyclonal antiserum  raised  to the 
electroeluted 43-kD protein or the affinity purified anti-43- 
kD  antibody  reveal  staining  patterns  (Fig.  2)  identical  to 
those seen with the antipeptide antibody.  Thus, at least one 
of the epitopes recognized by the anti-43-kD antibody is part 
of the smallest breakdown product (31 kD), which still con- 
tains  the amino terminus  of the molecule.  The anti-43-kD 
antiserum does not bind to the amino terminal peptide as as- 
sayed by  ELISA (data  not shown). 
Immunolocalization (I) 
lmmunoreactive Protein Is Found in both  Ventricle  and 
Atrium.  Sections through  frozen, ethanol-fixed tissue were 
incubated separately with each antibody. In theory, all regions 
of the antigen molecule are rendered accessible by the sec- 
tioning process.  In atrium  and  ventricle (papillary  muscle, 
The Journal of Cell Biology, Volume 108, 1989  2244 Figure  2.  Immunoblots  of  gap  junction 
preparations. Components of the gap junc- 
tion fractions were separated by electropho- 
resis as in Fig.  1 and blotted to nitrocellu- 
lose. Highly purified fractions  corresponding 
to Fig. 1 (lane 1) were run in lanes 1, 3, and 
5.  Partially  purified  gap junctions  corre- 
sponding to Fig. 1 (lane 2) were run in lanes 
2,  4, and 6.  (A) Blot probed with preim- 
mune serum (lanes 1 and 2) and the anti- 
43-kD antiserum before (lanes 3 and 4) and 
after affinity purifcation (lanes 5 and 6). 
(B)  Blot  probed  with  preimmune  serum 
(lanes I and 2) and the anti-amino terminus 
antiserum  (lanes  3  and  4).  The afffinity- 
purified antibody gives the same results (not 
shown). No binding is seen with either pre- 
immune serum.  The pattern of labeling is 
the same regardless of which antiserum or 
affinity-purified antibody is used. All rec- 
ognize the 43-kD polypeptide and the major products of its proteolysis at 35, 33, and 31 kD. In addition, all detect a sharp band migrating 
just below the 43-kD protein. This band is not always resolved, and we assume that it represents an intermediate stage of proteolysis. 
septum, or wall), the label is distributed in the pattern con- 
sistent with the known distribution of gap junctions. This is 
most clearly seen in sections of papillary muscle (Fig. 3 A 
and B) in longitudinally sectioned muscle bundles. Interca- 
lated disks form the transverse boundaries between cardiac 
myocytes and are the sites where gap junctions are predomi- 
nantly localized (Page and McCallister,  1973; Page,  1978; 
Sommer and Johnson,  1979). Unfortunately, in sections of 
rat  heart,  the  disks  are  not  clearly defined under  phase- 
contrast, differential interference contrast optics,  nor after 
staining  with iron-hematoxylin. The very distinct labeling 
pattern obtained with both antibodies nevertheless strongly 
suggests that it is the disks that are delineated. No reactive 
protein is  seen in  sections treated with preimmune serum 
(Fig. 3 C), nor with second antibody alone (data not shown). 
Both affinity purified antibodies also bind to protein pres- 
ent in sections taken from the atrium (data not shown). The 
pattern  of distribution  is  more complex than  in  ventricle 
since by examination of atrial muscle in the electron micro- 
scope the gap junctions are found both at the level of the in- 
tercalated disk and  in  areas of the sarcolemma where the 
cells are laterally apposed (Page, 1978). No immunoreactive 
protein was detected with either the anti-amino terminus or 
the anti--43-kD antisera when staining of liver cryosections 
was attempted (data not shown). 
Both Antibodies Bind to Cytoplasmic  Domains of the 
Gap Junction Protein.  Crude plasma  membrane and gap 
junction enriched fractions (which show contaminating pro- 
teins by SDS-PAGE, see above) were reacted with antisera 
under conditions in which the gap junctions were intact, so 
that only regions of the protein exposed at the cytoplasmic 
faces of the junction would be accessible to antibody. In thin 
sections of such preparations,  the pentalaminar profiles of 
gap junctions makes them readily distinguishable from other 
membranous structures. In fractions reacted with either an- 
tiserum as the primary antibody and then with gold labeled 
second antibody, only the gap junctions are specifically la- 
beled (Fig.  3, D  and E). The few gold particles elsewhere 
in the sections are distributed in no definite pattern, as is the 
case in sections reacted with the preimmune serum (Fig. 3 
F). No differences are discernable in the distribution of anti- 
gen detected by the anti-amino terminus antiserum and that 
detected by the anti-43-kD  antiserum.  In either case,  the 
amount of label varies from junction to junction and within 
different regions of the same junction. 
Topology of the Heart Junction Protein (II) 
To characterize further the cytoplasmic domains of the heart 
junction protein, we have used proteolytic enzymes believed 
to be too large to enter either the 2-nm gap separating the 
membranes  or  the  aqueous  channels  formed by  the  con- 
nexons (Goodenough and  Revel,  1971).  The junctions re- 
main intact after proteolysis and can be sedimented by cen- 
trifugation: the proteases and fragments of the polypeptide 
released by cleavage are not sedimented and are removed by 
decantation. Only those parts of the polypeptide protected 
from cleavage by association with the membrane are recov- 
ered and detected by SDS-PAGE and immunoblotting. 
Proteolytic cleavage of isolated gap junctions with TPCK 
trypsin produces small fragments migrating at Mr 14.5 and 
15-17  kD (Fig.  4  A).  Use of endoproteinase GIu-C under 
conditions in which the enzyme cleaves at the carboxy side 
of both glutamate and aspartate residues produces a similar 
digestion profile but the components recovered are larger. 
There is a well-resolved fragment of Mr 15.1 kD and a more 
diffuse band at Mr  17-19  kD  (Fig.  4  A).  Use of endopro- 
teinase Lys-C, which cleaves the polypeptide chain on the 
carboxy side of lysine residues, produces two major mem- 
brane-embedded fragments seen as a well-resolved band of 
Mr  15.6 kD  and  a  second broader band  of Mr  19-23  kD 
(Fig. 4 A). These results indicate the presence of two mem- 
brane-protected domains, represented by the two major pro- 
teolytic fragments, which are separated by an enzyme acces- 
sible cytoplasmic region, forming a cytoplasmic loop. 
To determine the position of these cleavage sites, isolated 
junctions were treated with proteases as described above and 
immunoblots of the resulting SDS-PAGE gels were probed 
with  the  antiserum  raised  against  the  amino  terminal  se- 
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junctions.  (A) Coomassie-stained gel of  heart gap  junction fractions 
(15 % acrylamide).  The control (lane 1 ) shows the prominent band 
at 43 kD that represents the parent molecule and the three easily 
formed breakdown products (35, 33, and 31 kD). In lane 2, the junc- 
tions  were treated  with TPCK trypsin;  in lane 3,  with endopro- 
teinase Glu-C; and in lane 4, with endoproteinase Lys-C. All three 
digests show a similar pattern:  two membrane-protected  domains 
appearing as a lower, well-resolved band (14.5, 15.5, and 15.6 kD) 
and a less well-resolved upper band (16-23 kD).  The faint bands 
seen in a ladder are believed to be aggregation products (see text 
and Fig. 5). (B) Western blots of heart gap junction fractions after 
proteolysis,  using the anti-amino terminal  antiserum.  Gap junc- 
tions  were treated  with the  same endoproteases  as in A.  Lane  1 
shows a control;  the other lanes show the result of treatment with 
TPCK trypsin  (lane 2), endoproteinase  Glu-C  (lane 3),  and en- 
doproteinase Lys-C (lane 4). The immunoblot shows that the lower, 
well-resolved  (membrane-protected)  fragment  is  stained  in each 
case; i.e., carries the amino terminal sequence. The ladder of  bands 
seen in the Coomassie-stained gel (Fig. 4 A) is also revealed by the 
site-directed antiserum.  Therefore, all these bands carry the amino 
terminus  and are probably aggregation products. 
quence. The lower, well-resolved band in each of the digests 
reacted positively while the upper band showed no reactivity 
(Fig.  4  B).  Therefore,  only the  15.6-,  15.1-, and  14.5-kD 
bands contain the amino terminal domain. 
Since the anti-amino terminus antiserum could still bind 
after exhaustive digestion, it was possible to investigate the 
size of the cytoplasmic loop by examining the products ot 
partial  enzymatic digestion.  By  sizing  the  fragments that 
reacted  with  the  antibody  on  immunoblots  (Fig.  5),  one 
obtains  a  nested  series  of fragments  retaining  the  amino 
terminus,  the  smallest having  an  Mr  of  14.5  kD  (trypsin 
digestion)  and the  largest having an Mr of 18.6 kD  (endo- 
proteinase  Lys-C  digestion).  The  difference  between  the 
smallest and largest fragments yields a minimum size for the 
cytoplasmic loop of '~4.1-kD. 
The  anti-amino terminus antiserum also  binds  to  some 
higher  molecular weight  species  (Fig.  4  B).  Presumably, 
these are aggregation products,  dimers,  and trimers of the 
amino terminus bearing peptides. Aggregation is a property 
commonly found  in  integral  membrane proteins  (Findlay, 
1987), and has been repeatedly observed in the case of gap 
junction  proteins  (Henderson  et al.,  1979;  Finbow et al., 
1980). The removal of polar residues from the 43-kD protein 
may exacerbate this problem by increasing the chance of hy- 
drophobic interactions. 
Antibody Binding Sites 
Two different antisera have been used in these studies.  The 
first is an antiserum raised against the amino terminus, and 
hence  its  binding  site  is  predetermined;  the  second  is  an 
antiserum  raised  against  electroeluted  43-kD  protein.  A 
binding  site of the affinity purified anti-43-kD antibody is 
detectable between two proteolytic cleavage sites. The lower 
band of Mr 15.1 kD seen after digestion with endoproteinase 
GIu-C,  reacted  positively  on  immunoblots.  However,  the 
lower band of Mr  14.5,  produced by TPCK trypsin diges- 
tion, failed to bind this antibody. In addition, none of the up- 
per, diffuse bands (15-17 kD) were detected by this antibody 
(Fig.  6). 
Thus, an antibody binding site, or a portion of a discon- 
tinuous binding site, is present in the cytoplasmic loop, local- 
ized within an 0.6-kD region, '~15 kD from the amino termi- 
nus.  There is also evidence (our unpublished observations) 
for at least one additional epitope on the carboxy terminal 
tail of the molecule. 
Functional Studies (III) 
Experimental Protocol. We used a two dye protocol to test 
junction  permeability because preliminary  studies  showed 
that if only one dye were used, as is usually done (Warner 
et  al.,  1984;  Hertzberg  et  al.,  1985),  false positives  (no 
transfer) could result after antibody injection.  We therefore 
first injected a tracer dye (LY or TR) to insure that the chosen 
cells  were coupled  before injection  of the  antibody.  Only 
those  cell  pairs which  showed uniform and  complete dye 
spread  were  selected  for  further  studies.  To test  whether 
these two dyes (LY, TR) would both label each of the cells 
Figure 3.  Immunolocalization  of the 43-kD protein.  (A) Indirect  immunogold-silver  stained section of longitudinally oriented papillary 
muscle reacted with afffinity-purified  anti-43-kD antibody. (B and C) Indirect immunofluorescence views of similar sections reacted with 
(B) affinity-purified anti-amino terminus antibody, and (C) preimmune serum (from anti-43-kD rabbit). No binding is seen with the preim- 
mune serum.  The distribution  of the immunoreactive protein detected by either antibody  is consistent with the known location of most 
gap junctions  in the region of the intercalated disk,  the site where myocytes interact end-to-end.  At the level of resolution obtained,  one 
cannot distinguish "end" from "lateral" junctions  that occur at the level of the disk.  (D, E, and F) Immunogold labeling of 43-kD protein 
in intact gap junctions.  Thin sections of partially purified gap junction  fractions reacted with (D) anti--43-kD antiserum;  (E) anti-amino 
terminus  serum;  and (F) preimmune  serum (from rabbit immunized with amino terminal peptide).  Binding of the primary antibody is 
detected with colloidal gold-labeled second antibody. In preparations probed with either of  the antisera (D and E), the immunogold labeling 
is restricted to the gap junctions  that are easily distinguishable by their pentalaminar profile. The density of label is variable from junction 
to junction  and occasional profiles of gap junctions  show no label.  Single membrane structures (i.e., nonjunctional  membranes) are not 
labeled. No components in the preparations  are labeled when preimmune serum is used as primary antibody. Bars, (A, B, and C) 50/,m; 
(D, E, and F) 0.3 /xm. 
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products of heart gap junctions using the amino terminal antiserum. 
Isolated gap junctions were treated with the same endoproteinases 
as in Fig. 4. However, the reaction was stopped after 30 rain to ob- 
tain partial proteolysis only. The smallest fragment produced had an 
Mr of 14.5 kD after trypsin digestion (lane 2), and the largest frag- 
ment recovered (18.6 kD) was formed after endoproteinase Lys-C 
digestion (lane 4). One can thus estimate the size of  the cytoplasmic 
loop to be ,,o4.1 kD. 
of individual pairs, we injected the same cell or each of the 
two cells of a pair with these dyes using separate microelec- 
trodes. In over 50 cell pairs tested, if the first dye transferred, 
the second one did also. In only five cases the first dye trans- 
ferred, but not the second. In all of these cases, small cell 
clumps rather than pairs were used,  and it is possible that 
the electrodes were inserted in cells other than those aimed 
for, because of the presence of undetected overlapping pro- 
cesses. The standard procedure was to inject one dye (e.g., 
LY) into one cell of a pair (or small cluster) to assay for nor- 
mal dye coupling. Antibody was then injected in either the 
same cell or one to which the first dye had spread. After a 
delay of 5-7 min, the other dye (e.g., TR) was injected into 
either cell of the pair, using another microelectrode. Observ- 
ing the transfer (or lack thereof) of the second dye permitted 
one to assess the effectiveness of the antibody injected. For 
an experiment to be scored as positive, the second dye should 
not enter (or leave), the cell that had received the antibody. 
Both Anti-Gap Junction Antibodies 
Block Dye Transfer 
Dye coupling  between  isolated  cardiac  muscle  ceils  was 
blocked by site-specific antibody directed against the amino 
terminal  sequence  of the  heart junction  protein  (Fig.  7, 
A-C). The pattern of injection with the second dye and anti- 
body was changed in different experiments without changing 
the result. Blockage of second dye transfer was observed in 
27 dye-coupled cell pairs after antibody injection (Table I). 
In three other coupled cell pairs, the effect  of antibody on dye 
transfer was uninterpretable, either because of incomplete 
filling of the cell injected with the second dye (transfer might 
not have been detectable even if it had taken place) or be- 
cause there was only weak transfer of the second dye. Such 
instances of partial blockage of dye transfer were rare but 
were considered uninterpretable because  it was  not clear 
whether the antibody had failed to act, or not enough time 
had been given to allow for complete closure of the junc- 
tional channels. 
Similar  results  were  obtained  with  the antibody  raised 
against  electroeluted gap junction protein  (Fig.  7,  D-F). 
Blockage of the transfer of the second dye was observed in 
24  dye-coupled cell  pairs  (Table  I).  In  another  six  dye- 
coupled pairs, the intracellular injection of the anti-43-kD 
antiserum did not prevent second dye transfer. In three fur- 
ther instances,  the effect of antiserum on dye transfer was 
uninterpretable (for reasons similar to those mentioned in the 
previous paragraph).  In either case, there was blockage of 
dye transfer by these antibodies whether or not the antibodies 
and second dye were injected in same cells or in different 
cells of a pair. 
Only Gap Junction Specific Antibodies 
Block Dye Transfer 
Preimmune  Serum.  In  one  set  of  control  experiments, 
preimmune serum against the site-specific polypeptide was 
injected in one cell of a dye-coupled cell pair (Fig. 8, A-C). 
No effect of preimmune serum on transfer of the second dye 
was observed in 22 coupled cell pairs. In another three cou- 
pled cell pairs, the effect of preimmune serum was uninter- 
pretable (for reasons similar to those mentioned above). 
Antibodies against Other Membrane Proteins. We tested 
whether inhibition of dye coupling observed in our study was 
because of the presence of lantibodies  specific to,the cardiac 
gap junction protein. For this set of experiments, we selected 
antipeptide antibody against rat lens MIP and one against 
cardiac G protein. MIP has no amino acid sequence homol- 
ogy  with  heart gap junction  protein  (Gorin et  al.,  1984; 
Beyer et al., 1987), and the antibody against it does not cross 
react with the heart junction protein (our unpublished obser- 
vations). This antibody should therefore serve as a control 
similar to preimmune serum.  We did not use an antibody 
against the 32-kD liver gap junction protein because this pro- 
tein has partial sequence homology with heart junction pro- 
tein (Nicholson et al., 1985), and at least one antibody to the 
Figure 6. Immunoblot analysis 
showing an antibody binding site 
of the  anti--43-kD antiserum. 
Blots of  the products of  digestion 
with endoproteinase GIu-C are 
seen in lane 1, and the pattern of 
antibody binding to products of 
TPCK trypsin treatment is dis- 
played in lane 2. Immnnoblot A 
was probed with the anti-amino 
terminal antiserum, and immu- 
noblot B was probed with the 
affinity  purified anti-43-kD anti- 
body. The lower band (Mr 14.5 
k) is not detected in B, indicat- 
ing that the binding site for this 
antibody  is  between  14.5 and 
15.1 kD. In A (lane 2) the upper 
band represents a dimer of the 
Mr 14.5 kD fragment. 
The Journal of Cell Biology,  Volume 108, 1989  2248 Figure 7. Antibodies specific to 45-kD heart gap junction protein block dye transfer. The left column (A and D) consists of phase-contrast 
photomicrographs of isolated pairs/clusters of cardiac muscle cells. The middle column (B and E) consists of photomicrographs of LY- 
labeled cells corresponding to those in the left column, respectively. Single cells in B and E were injected with LY. Subsequent transfer 
of LY to other cell(s) in pairs/clusters indicates normal dye coupling. The fight column (C and F) shows the effect of antibodies on the 
transfer of the second dye (TR). TR was injected 5-7 min after injections of antibodies. (A, B, and C) Antibody against a synthetic peptide 
corresponding to the first 20 amino acids of the 45-kD cardiac protein was injected into the bottom cell, and TR was then injected into 
the same cell (A). Note that the antibody prevented the transfer of TR to the other cell of the coupled pair (compare B to C). (D, E, and 
F) Antibody raised against electroeluted cardiac gap junction protein was injected into the left cell (D). Subsequent injection of TR into 
the lower right cell (D) was localized to that cell only. The blockage of dye transfer to other coupled cells (compare E to F) by the antibody 
also suggests that the upper right cell was not directly coupled to the lower right cell but through the left cell. Bar, 50 #m. 
32-kD protein has already been shown to affect dye coupling 
in adult rat cardiac myocytes (Hertzberg et al.,  1985). Fig. 
8 (D-F) shows that antibody against MIP has no effect on 
transfer of the second dye. A  similar observation was also 
made for another 20 dye-coupled cell pairs.  In three dye- 
coupled cell pairs, the second dye transfer appeared blocked 
(Table I). 
Table L Number of  CeU Pairs Tested  for the Effect 
of Various Antibodies and~or  Reagents on Transfer of  a 
Second Dye (TR or LY) 
Second dye 
Antibodies/ 
Reagents  Transfer  No transfer  Uninterpretable 
Site-specific  0  27  3 
antipeptide 
antibody 
Antibody to  6  24  3 
electroeluted 
43-kD band 
Preimmune  22  0  3 
serum 
Site-specific  21  3  0 
anti-MIP 
antibody 
Site-specific  8  1  0 
anti-G 
protein 
antibody 
Dextran  0  21  0 
The sequence of injection was dye  1, antibody,  dye 2.  Which dye was used 
first, or what cell was injected was random. The cell pairs listed in the uninter- 
pretable category are those that had incomplete filling  of the donor cell  with 
the second dye or a  weak transfer of it to the recipient cell(s). 
We also tested whether the blockage of dye transfer ob- 
served in our study was due to the effect of antibodies on the 
gap junction channel itself or could be an indirect result of 
antibody binding to other membrane proteins. In these ex- 
periments, we used an antibody that recognizes a G protein 
present in rat cardiac plasma membrane. Intracellular injec- 
tion of this antibody had no effect on the transfer of second 
dye (Fig. 8, G-l) in eight coupled cell pairs. In only one in- 
stance, the transfer of the second dye was inhibited by injec- 
tion of the antibody against G protein. 
Dye Exchange  Is  Via Structures of Restricted Perme- 
ability. The dye transfer observed was not due to the pres- 
ence of cytoplasmic bridges that might be present in the case 
of  dividing cells. This was tested by using rhodamine-labeled 
dextran (10,000) which is too large to pass through gap junc- 
tion channels. Typically, when labeled dextran was injected 
into one cell of an LY injected coupled cell pair it remained 
in the injected cell. A similar result was obtained in 21 cou- 
pled cell pairs studied (Table I). 
1tree Course of  Antibody Action 
When dye and antibody were coinjected there was always at 
least a partial transfer of dye. We chose to wait 5-7 min be- 
tween antibody injection and administration of the second 
dye because this schedule permitted complete blockage with 
the appropriate antibodies. P~irtial transfer resulted if  this de- 
lay was reduced. Presumably, time is needed for the antibody 
injection to have an effect, either because any needed confor- 
mational changes take place slowly or because the reagents 
diffuse to the site of action only slowly. 
Discussion 
Taken together, the results of our study illustrate the follow- 
Yancey et al.  The 43-kD Polypeptide of Heart Gap Junctions  2249 Figure 8. Control antibodies do not block dye transfer. Phase-contrast and fluorescence photomicrographs  are arranged as in Fig.  1. (A, 
B, and C) Preimmune  serum was injected into the left cell (A). Subsequent injection of TR into the right cell,  which has just received 
the preimmune serum, was transferred to the other cell of the coupled pair (compare B to C). A fluorescent spot on the lower left is due 
to uptake of TR by a floating debris.  (D, E, and F) Anti-peptide antibody against rat lens MIP was injected into the bottom left cell (D). 
TR was subsequently injected into the same cell.  Note that the antibody did not prevent the transfer of TR to the other cell of the pair 
that had been injected with the antibody (compare E to F). (G, H, and I) Site-specific antibody to the amino terminus of the beta 1 subunit 
of G protein was injected into the bottom cell (G). This antibody did not prevent the transfer of TR (injected into the top cell) to the bottom 
cell that had just received the antibody  (compare H to I). Bar, 50/zm. 
ing points:  (a) the 43-kD protein associated with gap junc- 
tions isolated from rat heart  is,  in  fact,  assembled in gap 
junctions in both the atrium and the ventricle; (b) the amino 
terminus of the molecule is exposed on the cytoplasmic side 
of the bilayer, that is, on the same side of the membrane as 
the  carboxy  terminus;  (c)  a  polypeptide  loop  that  binds 
affinity purified anti-43 kD antibody is also exposed to the 
cytoplasm. The protein, if it is transmembrane, is therefore 
likely to cross the membrane four times. (d) Both the amino 
terminus, and domains elsewhere on the cytoplasmic face of 
the junction can control junction permeability in the pres- 
ence of specific antibodies. 
The 43-kD Protein Is Part of  Heart Gap Junctions 
In immunocytochemical studies  of sections  of atrium and 
ventricle, the anti-43-kD and the anti-amino terminus anti- 
bodies show the same distinct pattern of distribution of im- 
munoreactive protein consistent with the known distribution 
of gap junctions  in  the  two tissues.  In longitudinally  sec- 
tioned papillary muscle from the ventricle, the pattern of im- 
munostaining  strongly  suggests  that  the  43-kD  protein  is 
concentrated at the region of the intercalated disk, the locus 
of numerous gap junctions.  That the protein detected in tis- 
sue sections is indeed a component of gap junctions is shown 
by the  specific binding  of both  antibodies  to  isolated  gap 
junctions. 
Topology of the Heart Gap Junction Protein 
Since the anti-amino terminus antibody binds to intact gap 
junctions,  where only cytoplasmic domains of the molecule 
are accessible for antibody binding, the determinants recog- 
nized by this antibody must be exposed at the cytoplasmic 
face of the junction.  The complete amino acid sequence of 
the 43-kD protein, obtained by cDNA sequencing (Beyer et 
al.,  1987), shows no other regions of the molecule homolo- 
gous with the sequence of the amino terminal peptide that 
we used as antigen.  It has previously been shown that the 
protein has a domain of about 17 kD at its carboxy terminus, 
which is lost by proteolysis during isolation (Manjunath et 
al.,  1987) and must therefore be exposed on the cytoplasmic 
face of the junction. Since amino and carboxy termini are on 
the same side of the membrane, the protein,  if transmem- 
brane, must be folded in a configuration such that it crosses 
the membrane an even number of times.  One can a  priori 
imagine domains where portions of the polypeptide enter the 
membrane and then come out on the same side, rather than 
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been proposed in the case of other membrane proteins. Re- 
verse turns usually involve polar residues and occur mostly 
at the surfaces of  proteins (Schultz and Schirmer, 1979). The 
43-kD protein is shown to be an integral membrane protein 
by its solubility characterisitics. It remains membrane bound 
after exposure to high salt buffer during the isolation pro- 
tocol and in the presence of  0.33% sarkosyl and 0.1% sodium 
deoxycholate, but is solubilized by SDS. It can only be de- 
graded partially by exogenous proteases and has an hydro- 
phobicity profile (Kyte and Doolittle, 1982)  suggesting the 
presence of four domains, characteristic of protein trans- 
membrane regions. However,  while the circumstantial evi- 
dence is strong, we present here no direct experimental evi- 
dence for the protein to be transmembrane since we have 
only studied the distribution of cytoplasmic determinants. 
Since the anti-43-kD antiserum also binds to intact gap 
junctions, at least one of the determinants recognized by this 
antiserum must be exposed on the cytoplasmic face of the 
junction.  On  Western blots,  the affinity purified antibody 
recognizes the  15.1-kD amino terminal fragment produced 
by endoproteinase GIu-C but not the corresponding fragment 
seen after digestion with trypsin. Therefore, at least one of 
the determinants recognized by this antibody must lie on a 
cleavable loop between two domains that remain unaffected 
by proteolysis, presumably because they were protected by 
association with the membrane. 
The presence of the three cytoplasmic domains indicates 
that the heart 43-kD protein could cross the membrane four 
times (Fig. 9). The hydropathicity plot (Kyte and Doolittle, 
1982) based on the sequence shows four strongly hydropho- 
bic regions of appropriate length. Analysis of the sequence 
using the method of Klein et al. (1985),  predicts four trans- 
membrane helices: amino acid residues 20-40, 77-100,  154- 
173, and 203-234.  Similarly, the Rat and Argos (1986) al- 
gorithm predicts four transmembrane helices: amino acid 
residues 19-41,  7%97,  149-184,  and 207-233.  If the poly- 
peptide completely spans the membrane, presumably as al- 
pha helices '~20 amino acids long, there must be two ex- 
tracellular domains. The predicted extracellular domains are 
regions which contain numerous residues that should in the- 
try be cleavable by the proteases used in our experiments. 
The fact that they are not cleaved supports the idea that these 
residues are found in domains inaccessible to our reagents, 
quite possibly the narrow gap between extracellular faces of 
apposed junctional membranes which is not permeable to 
proteins (Goodenough and Revel, 1971). The aqueous envi- 
ronment in the gap would be favorable for the putative extra- 
cellular loops that are shown by sequence analysis to contain 
highly conserved charged and other hydrophilic residues. 
Milks et al. (1988) present data showing the presence of such 
an extracellular loop in liver junctions, supporting the above 
arguments by homology. 
Characterization of the Cytoplasmic Loop 
The size of the cytoplasmic loop has been estimated to be 
,x,4.1 kD. This represents a minimum value that is dependent 
on the location of  accessible cleavage sites. Additional uncer- 
tainties about the size of the loop are introduced by the lack 
of precision of molecular mass estimates based on SDS- 
PAGE (see Materials and Methods, SDS-PAGE).  The exact 
position of the cytoplasmic loop as determined by our data 
is therefore not absolutely certain. However,  the estimated 
size of the amino terminus bearing protease resistant domain 
is such that it would seem reasonable to place the cytoplas- 
mic loop between the second and third predicted transmem- 
brane segments. This region contains one of the most hydro- 
philic regions of the molecule and is predicted to carry an 
antibody binding site (Hopp and Woods, 1981), located in the 
general portion of the sequence where we identify such a site 
or part of one. 
The Amino Terminus 
A surprising result of our studies is the apparent accessibility 
of the amino terminus to antibodies but not to proteolytic en- 
zymes. The possibilities to account for this puzzle include 
(a) the proteolytic enzymes do remove some amino terminal 
sequence but enough of the sequence remains to allow bind- 
ing of the anti-amino terminus antiserum; (b) the active site 
of the enzyme cannot sufficiently approach the amino termi- 
nus for cleavage while the antigen binding site is present at 
the end of an arm of the antibody molecule and is therefore 
less sterically hindered from binding. The definitive explana- 
tion will have to wait for conclusive determination of the 
amino terminal sequence of  the molecule after digestion with 
specific proteases. 
How Many Proteins Are Present in 
Heart Gap Junctions? 
Our results indicate that the 43-kD band seen on gels repre- 
sents protein that is a component of gap junctions in cardiac 
muscle, but is it the only protein present? An occasional 
profile of a gap junction in our preparations showed no label- 
ing with the colloidal gold-linked antibody. These junctions 
could originate in vascular smooth muscle or endothelial 
cells  since we have observed no staining in sections that 
could be ascribed to these sources. It could also be that the 
binding sites for the first or second antibody are sometimes 
physically inaccessible  during  the  incubation because  of 
clumping of  the membranes. The overall intensity of labeling 
was increased when the concentrations of first and second 
antibody were increased. The results of dye coupling experi- 
ments suggest that binding antibodies to the 43-kD protein 
is essential and sufficient to control transfer of small mole- 
cules between cardiac myocytes. We cannot now rule out, 
however,  the possibility that more than one protein is in- 
volved in the formation of the gap junctions as has been 
shown for the liver (Nicholson et al., 1987). Other proteins, 
however,  would have to act cooperatively with the 43-kD 
polypeptide. 
It has  been  suggested  (Hertzberg  and Skibbens,  1984; 
Evans et al., 1988), that the liver 32-kD protein (then called 
27 k) is a component of gap junctions in heart.  This con- 
clusion has not been supported, however,  by the results of 
Northern blot screening with the cDNA probe for the message 
that encodes the liver protein (D.  Paul,  1986;  our unpub- 
lished observations). We have also eliminated the possibility 
that we are detecting the liver protein with our antibodies. 
Neither of our antibodies cross react with either of the pro- 
teins that have been identified with liver gap junctions (our 
unpublished observations) nor do they immunolabel tissue 
sections from liver. 
A species of mRNA is found in lens fiber cells and in heart 
that encodes a protein of 43-kD homologous at its amino ter- 
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et at.,  1988).  Our anti-amino terminus antibody, however, 
does not show cross-reactivity with protein in homogenates 
of lens  fibers  (Kadle  et  al.,  manuscript  in  preparation). 
Given this lack of cross-reactivity and the similarities in dis- 
tribution of immunoreactive protein we observe with the 
anti-43-kD  and anti-amino terminus antibodies,  it is un- 
likely that we are detecting the 46-kD protein in the heart. 
Its location remains to be defined. 
Comparison of the Topology Proposed  for Different 
Junction Proteins 
The analysis of the primary sequence of junctional proteins 
has suggested that the different molecules that have been rec- 
ognized share a number of features, in particular that there 
are four transmembrane segments, separated by two highly 
conserved extramembrane loops on one side and three do- 
mains on the other, including the amino and carboxy termini. 
A  recently published experimental paper  by Milks et al. 
(1988) amplifies the previously published results of several 
investigators (Hertzberg et al.,  1988;  Zimmer et al.,  1987) 
and shows that these predicted features are in fact correct in 
so far as the 32-kD liver protein is concerned. We show here 
(Fig. 9) that this is the case for the heart 43-kD protein as 
well.  Thus, it appears that different gap junction proteins 
might well have a  similar organization with respect to the 
membrane. 
Effect of  Antibodies on Dye Coupling 
Our results show that intracellular microinjections of the 
anti-amino terminus antiserum and the anti-43-kD antise- 
rum both block cell-cell communication as measured by 
blockage of dye transfer between neonatal cardiac myocytes 
in culture. On the other hand, preimmune serum, antiserum 
against a  noncardiac putative gap-junction protein (MIP), 
and affinity purified antibody against a  non-gap junction 
membrane protein (G protein) have little or no effect on dye 
coupling. These data support the notion that 43-kD protein 
from cardiac tissue is a  functional part of heart gap junc- 
tional channels. Since injected antibodies have access only 
to the cytoplasm, the observed blockage of dye coupling sug- 
gests that some of the domains of this protein responsible for 
gating are exposed to the cytoplasm. The finding that a site- 
specific antibody raised against the first 20 amino acids of 
the heart junction protein is effective in interfering with dye 
transfer,  reinforces the idea that the amino terminal portion 
of the molecule is exposed to cytoplasm as already indicated 
by the fact that this antibody binds to intact gap junctions. 
The polyclonal antibody raised to electroeluted  junction pro- 
tein reacts with epitopes located in the cytoplasmic loop and 
also with some at the carboxy tail (our unpublished observa- 
tions) but does not recognize the amino terminus of the mole- 
cule.  Since both antibodies block dye transfer,  our results 
would suggest that there may be several domains of  the mole- 
cule that are involved in regulating gap junction channel per- 
meability. An alternate view would be that it suffices to inter- 
fere with any domain: binding of antibody to any exposed 
part of the polypeptide produces a sufficient conformational 
change such that it always blocks transfer. If this were indeed 
the case, antibodies (at least whole antibodies) would be use- 
less in functional mapping of the gap junction protein.  To 
fully answer this question, it will be necessary to use anti- 
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Figure 9. Topology of the heart 43-kD protein. This schematic dia- 
gram illustrates the arrangement of the heart 43-kD protein that can 
be deduced from the data presented. The numbers refer to fragment 
size in kilodaltons. There are three cytoplasmic  and two extracellu- 
lar domains. Cognate antibody binding sites are shown  by stippling. 
bodies directed against several  other particular epitopes, as 
well as other approaches to sort out the various possibilities. 
The lack of blockage of dye coupling in presence of an an- 
tibody against G protein further suggests that blockage of dye 
coupling in cardiac tissue is not because of a generalized 
effect of antibody binding to membrane. Jaslove and Brink 
(1987)  have discussed potential artefacts that might arise 
when testing for cell-cell communication by dye coupling. 
In our experiments, dye transfer cannot reflect the rupture of 
junctional membranes because it was blocked by specific an- 
tibodies only. Blockage of dye transfer by changes in intracel- 
lular pH or pCa is unlikely because we should have observed 
similar blockage in control injections. Finally, the dyes used 
were not taken up from the extracellular medium. We did test 
for such a possibility by introducing a large amount of LY 
and TR dyes in the extracellular bath (data not shown). 
Dye Transfer Versus Electrical Coupling 
With a  few exceptions  (Kaczmarek et al.,  1979;  Muller, 
1981; Warner and Lawrence, 1982; Murphy et al., 1983; and 
Bodmer et al., 1988), electrical coupling is always accompa- 
nied by dye coupling, and dye coupling has been a criterion 
to assess coupling via gap junctions (for review,  see Spray 
and Bennett,  1985).  There are  a  few instances,  however 
where dye coupling but not electrical coupling has been 
found  (Kuhnt  et  al.,  1979;  Zieglgansberger  and  Reiter, 
1974). Dye coupling is not a very sensitive measure of cell- 
cell communication and often a weak electrical coupling is 
not revealed by dye coupling (Murphy et al., 1983). In fact, 
we chose to use dye coupling because in these early studies 
we wanted to make sure that we would be looking only at 
large, clear-cut effects, rather than examining fine modula- 
tions of  permeability that might be more difficult to interpret. 
Since we assayed dye coupling only, it is possible that our 
experimental protocol might not have been effective in block- 
ing of electrical coupling between cardiac myocytes. Hertz- 
berg et al. (1985) have shown that antibodies against a liver 
gap junction protein reduces both electrical and dye coupling 
between cells of cardiac, liver,  and neural tissues (see also 
Warner et al.,  1984). 
Conclusions 
We conclude from our studies that the 43-kD polypeptide 
localized in  isolated cardiac gap junctions is  involved in 
The Journal of Cell Biology, Volume  108,  1989  2252 cell-cell communication mediated by gap junctions. Our ex- 
perimental data supports the models of the junction protein 
that can be derived from an analysis of primary sequence; 
its arrangement  in the membrane is similar to that of other 
junction proteins. Our work also suggests that the amino ter- 
minus as well as other regions of the molecule are possible 
functional  domains  somehow involved in gating  the junc- 
tional channels. Subject to the caveats discussed above, anti- 
bodies  against  particular  domains  of a junctional  protein 
could be a potential tool for understanding the gating proper- 
ties, tissue specificity, and physiological function of cell-cell 
communication. 
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